NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
33 month
Value
£1B
Sector
HEALTH
Published
20 Jan 2025
Delivery
01 Apr 2025 to 31 Dec 2027
Deadline
13 Sep 2024 12:00

Concepts

Location

Geochart for 1 buyers and 6 suppliers

1 buyer

6 suppliers

Description

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.

Award Detail

1 CSL Behring (Milton Road Haywards Heath)
  • Value: £905,187,090
2 Bio Products Laboratory (Elstree)
  • Value: £905,187,090
3 Takeda (None)
  • Value: £905,187,090
4 Grifols (London)
  • Value: £905,187,090
5 Octapharma (Manchester)
  • Value: £905,187,090
6 LFB (Avenue Des Tropiques)
  • Value: £905,187,090

CPV Codes

  • 33651520 - Immunoglobulins

Indicators

  • Contract is suitable for SMEs.

Other Information

Framework Agreement - Redacted Framework Agreement - Redacted.pdf

Reference

Domains